Current Valuation
$129.2M
As of February 12, 2025
Total Funding Raised
N/A
Last Round
Secondary Transaction - Private

$27.6M

Last Funding
Feb 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Inibio is currently valued at $129.2M as of February 12, 2025.

Investment Perspective

Inibio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Inibio Valuation Updates

Get notified when Inibio raises new funding or valuation changes

What is Inibio Worth in 2025?

As of 2025, Inibio is valued at $129.2M, based on the company's Secondary Transaction - Private funding round in February 12, 2025. This valuation positions Inibio as one of the leading private companies in the sector.

Inibio Valuation History

Inibio's funding history demonstrates steady growth and investor confidence.

How Inibio Valuation is Determined

Private company valuations like Inibio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Inibio Valuation FAQs

Is Inibio profitable?

Inibio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Inibio's valuation compare to competitors?

Inibio is valued at $129.2M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Inibio IPO?

Inibio has not announced plans for an initial public offering. Until an IPO, investors can access Inibio shares through secondary market platforms.